Mariany H Miyamoto, Marcos N Goularte, Ruan Pablo S Gomes, Giovana S Gaio, Gabriel Erzinger, Diego Lima
{"title":"Direct superior approach versus posterior approach in patients with primary total hip arthroplasty: a systematic review and meta-analysis.","authors":"Mariany H Miyamoto, Marcos N Goularte, Ruan Pablo S Gomes, Giovana S Gaio, Gabriel Erzinger, Diego Lima","doi":"10.1177/11207000261422440","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>The benefits and risks of the minimally invasive direct superior approach (DSA) compared with the posterior approach (PA) in primary total hip arthroplasty (THA) remain uncertain.</p><p><strong>Methods: </strong>We performed a systematic review and meta-analysis comparing DSA and PA in primary THA. Outcomes included perioperative parameters, radiological and functional results, and postoperative complications. Statistical analysis was performed using Review Manager, with heterogeneity assessed using I<sup>2</sup>. Subgroup analyses were restricted to randomised controlled trials (RCTs).</p><p><strong>Results: </strong>11 studies comprising 5217 patients were included, with 1259 undergoing DSA. DSA was associated with a shorter hospital stay (MD -0.67 days; <i>p</i> < 0.00001), reduced blood loss (MD -66.09 mL; <i>p</i> = 0.007), and increased Harris Hip Scores (HHS) within 3 months (MD 1.00; <i>p</i> = 0.03). No significant differences were observed in operating time, radiological outcomes, Oxford Hip Score, Western Ontario and McMaster Universities Osteoarthritis Score, 12-month HHS, or postoperative complications. Subgroup analysis revealed differences between RCTs and observational studies in length of stay (<i>p</i> < 0.0004), leg-length discrepancy (<i>p</i> = 0.07), and operating time (<i>p</i> = 0.04).</p><p><strong>Conclusions: </strong>DSA appears to be a safe, effective alternative to PA, providing less blood loss, shorter hospitalisation, and faster early recovery without compromising mid-term outcomes.</p>","PeriodicalId":12911,"journal":{"name":"HIP International","volume":" ","pages":"713-722"},"PeriodicalIF":1.3000,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"HIP International","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/11207000261422440","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/5 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: The benefits and risks of the minimally invasive direct superior approach (DSA) compared with the posterior approach (PA) in primary total hip arthroplasty (THA) remain uncertain.
Methods: We performed a systematic review and meta-analysis comparing DSA and PA in primary THA. Outcomes included perioperative parameters, radiological and functional results, and postoperative complications. Statistical analysis was performed using Review Manager, with heterogeneity assessed using I2. Subgroup analyses were restricted to randomised controlled trials (RCTs).
Results: 11 studies comprising 5217 patients were included, with 1259 undergoing DSA. DSA was associated with a shorter hospital stay (MD -0.67 days; p < 0.00001), reduced blood loss (MD -66.09 mL; p = 0.007), and increased Harris Hip Scores (HHS) within 3 months (MD 1.00; p = 0.03). No significant differences were observed in operating time, radiological outcomes, Oxford Hip Score, Western Ontario and McMaster Universities Osteoarthritis Score, 12-month HHS, or postoperative complications. Subgroup analysis revealed differences between RCTs and observational studies in length of stay (p < 0.0004), leg-length discrepancy (p = 0.07), and operating time (p = 0.04).
Conclusions: DSA appears to be a safe, effective alternative to PA, providing less blood loss, shorter hospitalisation, and faster early recovery without compromising mid-term outcomes.
期刊介绍:
HIP International is the official journal of the European Hip Society. It is the only international, peer-reviewed, bi-monthly journal dedicated to diseases of the hip. HIP International considers contributions relating to hip surgery, traumatology of the hip, prosthetic surgery, biomechanics, and basic sciences relating to the hip. HIP International invites reviews from leading specialists with the aim of informing its readers of current evidence-based best practice.
The journal also publishes supplements containing proceedings of symposia, special meetings or articles of special educational merit.
HIP International is divided into six independent sections led by editors of the highest scientific merit. These sections are:
• Biomaterials
• Biomechanics
• Conservative Hip Surgery
• Paediatrics
• Primary and Revision Hip Arthroplasty
• Traumatology